AI Doc will Leverage Innovative Knowledge Management System
and proprietary Database and Scorecards to Guide Investment
Decisions
NEW
YORK, July 31, 2024 /PRNewswire/ -- In a
healthcare marketplace where Artificial intelligence (AI) holds
enormous potential, Zoi Capital is excited to announce the
launch of its AI Doc Platform, a novel internal tool designed to
identify high-potential use cases and companies in health AI.
As AI continues to show significant potential in healthcare, Zoi
Capital is committed to investing in the next generation of health
AI technologies with a distinctive investment strategy. Co-founded
by Dr. Ronald M. Razmi, a Mayo
Clinic-trained cardiologist, digital health CEO, and author of the
new book "AI Doctor: The Rise of Artificial Intelligence in
Healthcare," Zoi Capital is pioneering a new paradigm for private
market investing.
Dr. Razmi, along with a team of digital health investors and
operators, bring clinical, operating, and investment experience to
the table. Co-Founders Brian Beeler and Dr. Ronald M. Razmi together boast an impressive
track record with exits exceeding $30
billion via public markets and acquisitions.
"Given the increasing complexity of sectors such as healthcare
and technologies like AI, achieving high returns on capital and
ensuring that the best use cases and technologies are funded
requires specialization and focus," said Dr. Razmi.
To create a scalable and repeatable approach for evaluating AI
solutions that address critical issues in healthcare, Zoi Capital
has developed proprietary scorecards. These scorecards evaluate
both the use cases targeted by health AI companies and the
companies themselves. This methodology ensures the identification
of high-priority use cases and companies that effectively navigate
the barriers to adoption.
"The buyers of these technologies have to wade through numerous
digital solutions with limited budgets, so they will only choose
those that address their most important needs," Dr. Razmi
explained. "Identifying these use cases should be the foundation of
any investment strategy for health AI. Once the use cases are
pinpointed, finding companies with technologies and business models
that solve technical, clinical, and business barriers will be
critical."
Brian Beeler, co-founder of Zoi
Capital, added, "In order to usher in a new era of deploying
capital into the best use cases and companies, methodical
assessment by specialists will be the key to success."
The AI Doc Platform, Zoi Capital's comprehensive investment
tool, includes:
- Knowledge Management System: This system breaks the
healthcare space into 18 sub-sectors, tracking key unmet needs,
business trends, and emerging technologies in each area.
- Comprehensive Database: The database encompasses
thousands of digital health companies, detailing their
technologies, the use cases they address, investors, customers,
funding, and more.
- ZoiCare Scorecards for Investment Excellence (Z-Six):
These scorecards ensures that only the highest priority use cases
for technology buyers are considered for investment, and that
selected companies are solving for the adoption barriers that have
hindered many promising technologies.
This approach guides Zoi Capital's investment decisions and
provides a framework for entrepreneurs to refine and position their
innovations for success in the complex healthcare landscape.
If you would like to learn more about how Zoi Capital is
uniquely positioned to lead the charge as the healthcare industry
stands on the brink of an AI-driven transformation, please do not
hesitate to reach out to schedule a time to speak with Dr. Razmi
and/or Brian Beeler.
For more information, please visit: www.zoicap.com
About Zoi Capital
Zoi Capital is a thematic venture capital firm that
specializes in the growing applications of artificial intelligence
in healthcare.
Led by Brian K. Beeler, a former
life science company executive that has been involved with managing
multiple corporate venture funds and over $7
billion in transactions, and Dr. Ronald M. Razmi, former Cardiologist, McKinsey
consultant, CEO of Acupera, and author of the new book, AI
Doctor: The Rise of Artificial Intelligence in Healthcare, the
firm's competitive advantages include cross-functional expertise in
practicing medicine, operating successful digital health companies,
and investing in medical technologies.
With the help of their proprietary investment platform, AI Doc,
Zoi Capital is able to find and select companies with technologies
that provide immediate benefit to healthcare stakeholders while
solving for the unique friction points that usually derail or delay
adoption. While relationships with top academic medical centers
provide access to unique deal flow, Zoi plays an active role in
improving the product road map, optimizing commercialization
strategy, and facilitating faster exits.
Press Contact: Michelle
Moskowitz, 917-597-0863
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zoi-capital-announces-health-ai-investment-tool-ai-doc-to-identify-high-potential-use-cases-and-technologies-302210953.html
SOURCE Zoi Capital